Repligen
RGEN
#2602
Rank
C$9.33 B
Marketcap
C$165.53
Share price
0.01%
Change (1 day)
-4.20%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of December 2025 : C$0.95 Billion

According to Repligen 's latest financial reports the company's total debt is C$0.95 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2025-12-31C$0.94 B-4.05%
2024-12-31C$0.98 B4.31%
2023-12-31C$0.94 B64.5%
2022-12-31C$0.57 B23.03%
2021-12-31C$0.46 B32.84%
2020-12-31C$0.35 B2.11%
2019-12-31C$0.34 B143.96%
2018-12-31C$0.14 B12.97%
2017-12-31C$0.12 B-2.54%
2016-12-31C$0.12 B
2005-03-31C$0.14 M29.94%
2004-03-31C$0.11 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
C$88.39 B 9,170.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$54.42 B 5,608.40%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$28.32 B 2,870.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$65.14 B 6,732.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$35.13 M-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.34 B-63.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.57 B-39.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.48 B-49.14%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.83 B-12.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$3.55 B 272.55%๐Ÿ‡บ๐Ÿ‡ธ USA